Presented by


Event sponsors

McKesson McKesson

Agency partners

Enterprise Ireland Enterprise Ireland
IDA Ireland IDA Ireland
InterTrade Ireland InterTrade Ireland
Science Foundation Ireland Science Foundation Ireland

Pharma Patrons


When AbbVie was formed in 2013, we seized a rare opportunity: to build on Abbott’s 125-year experience and heritage in health by infusing the agility, passion and focus of a start-up business.

With patients at the heart of all we strive for, we are proud that AbbVie in Ireland delivers world-class discovery, production and supply of critical medicines. We’re a modern biopharmaceutical business with a significant footprint in Ireland that’s focused on novel and breakthrough therapies for tough-to-treat diseases and unmet medical needs, with a reputation for quality.

AbbVie is spread across five sites in Ireland. Alongside three manufacturing facilities in Sligo and Cork, two offices in Dublin serve the needs of the company’s Commercial and Operations activities.

Our company creates new medicines for chronic, serious health issues by combining advanced science with deep knowledge of diseases. We harness Irish expertise in complex chemical and biological research, testing discoveries through clinical trials as well as manufacturing many of our medicines and delivery devices here in Ireland.

In this way, Ireland contributes to every part of the medicine discovery process before our commercial team works to make these new treatments rapidly.


Alexion is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing therapies.

Since its founding in 1992, Alexion has given hope to people who had none and shined a light on those who felt isolated and alone. But we know that fighting rare diseases takes so much more than hope. It requires persistence, dedication, and a relentless pursuit of the highest levels of medical innovation. At Alexion, our goal is to deliver medical breakthroughs where none currently exist. We are driven because we know people's lives are at stake.
Alexion has 3,000 passionate and dedicated employees serving patients in 50 countries around the world. Alexion’s investment in Ireland is one of the largest healthcare investments in the country. Alexion is investing in the future of Ireland and offers employment opportunities at the cutting edge of science and innovation, with currently > 600 highly skilled & talented people employed in our 2 sites.

Our state-of-the-art facilities in Ireland allow us to produce and export life-transforming treatments to our patients globally
The College Park site, home to >400 people, is a multi-capability site with Bulk Drug Substance Manufacturing, Commercial & Clinical Secondary Packaging, QC Global Centre of Excellence, Quality Assurance Release & Certification, External CMO Management, Global Supply Chain, Finance, HR and IT Functions
The Athlone site, home to >200 people, has capabilities in Aseptic Drug Product Manufacturing, Commercial Drug Substance Purification and Clinical Drug Substance Manufacturing

Astellas Pharma

Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 16,000 people globally. A young and forward-thinking company, Astellas is dedicated to improving the lives of people around the world through providing innovative and reliable pharmaceutical products. Astellas’ key strengths lie in the therapy areas of Transplantation, Urology and Oncology.
Formed in 2005 through the merger of Yamanouchi and Fujisawa, Astellas continues to remain committed to developing first-in-class and best-in-class products. With significant ongoing investment in R&D, Astellas continues to strengthen its capabilities as a research-driven pharmaceutical company, bringing effective therapies to patients around the world and continuing to build trusted networks amongst physicians and partners. With healthcare is in an era of unprecedented change and progress, new scientific discoveries combined with advances in technology are deepening our understanding of disease and creating an array of potential new medical solutions. Our vision is to be on the forefront of this changing healthcare environment, turning innovative science into valuable new treatment options for patients.
In Ireland Astellas employs nearly 400 people. Based across two manufacturing sites in Killorglin, Co.Kerry and Mulhuddart, Co.Dublin. and a sales and marketing office in Citywest Dublin, Astellas has a long-standing reputation in Ireland.

BioPharmaChem Skillnet

BioPharmaChem Skillnet was established in 2006 with the aim of fostering a climate of whole-company development in the provision of Industry Specific technical training and non technical training within the Pharmaceutical, BioPharma, Chemical, and Medical Device sectors.
We work in partnership with our Member Companies to design and deliver Enterprise-Led, subsidised training solutions for Industry. We are actively involved in the promotion of the value of life long learning and the importance of ongoing professional development. We seek to address gaps in existing educational provision while also working with industry to identify future skills requirements. We also deliver best practice workshops which actively promotes networking between our Member Companies.

Bristol-Myers Squibb

Bristol-Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, haematology, immunology, cardiovascular and neuroscience. Our employees work every day to transform patients’ lives through science.

Bristol-Myers Squibb has been in operation in Ireland since 1960, employing over 600 people across a range of activities and business units. Many of our global business services, including Bristol-Myers Squibb European Treasury Centre, Global Bio Lab and Global Supply Chain and Logistics are based on the island of Ireland.

It is also home to the Global headquarters of External manufacturing, which is responsible for the management of manufacturing contract operations (CMO’s) and reliable supply across the Bristol-Myers Squibb global network.

Located in Dublin, Cruiserath Biologics Campus a one billion Multi-Product Cell Culture Biologics Manufacturing facility, which is a part of the Global Product Development and Supply (GPS) network. This state of the art facility will produce multiple therapies for the company’s growing biologics portfolio and a central role in BMS’ global manufacturing network.

The Global Biologics Laboratory is also located on the Cruiserath campus. This laboratory is responsible for the release testing of Biologics Drug product for the BMS network.

Celgene and Juno Therapeutics are wholly owned subsidiaries of Bristol-Myers Squibb Company. In certain countries outside the U.S., due to local laws, Celgene and Juno Therapeutics are referred to as, Celgene, a Bristol-Myers Squibb company and Juno Therapeutics, a Bristol-Myers Squibb company.

For more information about Bristol-Myers Squibb, visit us at

Eli Lilly

Lilly is a global healthcare leader that unites caring with discovery to create medicines that make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees
work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism

Lilly has been operating in Ireland for almost 40 years and employs over 1,500 people across a range of activities including biopharmaceutical manufacturing and commercialisation, global business services, marketing and sales.

At our manufacturing campus in Kinsale, Lilly employs around 800 people, making medicine using both chemical synthesis & biotechnology manufacturing processes. Lilly Kinsale makes medicines for the treatment of illnesses across a range of therapeutic areas including oncology, immunology and diabetes. In 2019, the Lilly Kinsale continuous drug substance manufacturing facility was selected as the global category winner for “Process Innovation”, in the prestigious International Society of Pharmaceutical Engineers “Facility of the Year” awards. The company is also investing in a significant expansion to the biotechnology capacity at the site, which is targeted for completion in 2021.

Our global business solutions centre in Little Island, Co. Cork employs around 750 people; with 44 languages spoken across the 38 nationalities that are represented in the employee population. The centre provides business services in areas such as finance, customer meeting services, medical information, clinical trial capabilities and more. In 2019, the centre significantly expanded its operations with the opening of a new office block that doubled the size of its previous footprint and which will facilitate its continued growth in new and innovative service areas in the future.

To learn more about Lilly, please visit us at /

Innopharma Group

Innopharma are a group of companies who work together to bring the future of manufacturing forward.

Our technology, education and services divisions are leading the way in the development of solutions, learning and people to progress the world’s pharmaceutical industry through advanced skills and technologies.


At Janssen, the Pharmaceutical Companies of Johnson & Johnson, we are uniquely positioned and privileged to make a positive difference to the lives of patients and their loved ones, at all stages of life. In Ireland, we employ over 800 dedicated individuals1 across our commercial and manufacturing sites in Dublin and Cork who are inspired to help find new and better ways to prevent, intercept, treat and cure some of the most complex medical challenges of our time.
Building on over 100 years of scientific heritage, we focus our efforts on developing transformational treatments for patients across six distinct areas of healthcare:
Infectious diseases and vaccines
Cardiovascular and metabolic diseases
Pulmonary hypertension.
We bring together the best minds and pursue the most promising science to solve problems and find solutions for diseases where the unmet need is great.
Driven by the Johnson & Johnson Credo alongside our enduring commitment to patients and their families, our people and our local communities - we work in trusted, transparent partnerships with patient organisations, healthcare professionals and the Health Service Executive to make a real difference where it matters most. We have been involved in some of the biggest breakthroughs in medicine since we first arrived in Ireland. We want Ireland and Irish patients to benefit from the breakthroughs we will make over the decades to come. That is why we are here.
We are Janssen. We are working to create a world without disease. To learn more, visit our website:


Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develop, manufacture, market and distribute specialty pharmaceutical products and therapies. The company's Specialty Brands reportable segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. Its Specialty Generics reportable segment includes specialty generic drugs and active pharmaceutical ingredients. To learn more about Mallinckrodt, visit


MSD Ireland is one of the country’s leading healthcare companies, having first established here over 50 years ago. We currently employ approximately 2,300 employees, across five sites in Ballydine, Co Tipperary, Brinny, Co Cork, Carlow and Dublin and, in addition, operate substantial Human Health and Animal Health businesses. In total to date, we have invested $2.5 billion in our Irish operations and our annual turnover ranks us as one of Ireland’s top 20 companies. Our Irish sites manufacture approximately half of MSD’s top twenty products, saving and enhancing lives in over sixty countries around the world.


Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. Novartis is currently conducting over 21 clinical trials in Ireland. About 105 thousand people of more than 140 nationalities work at Novartis around the world and over 1,200 in Ireland in commercial operations in Dublin and manufacturing in Cork.


At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of human medicinal products. Our diversified global health care portfolio includes human biologic and small molecule medicines and vaccines, as well as many of the world’s best-known consumer products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.
Pfizer’s business interests in Ireland are diverse. There is a manufacturing presence in Active Pharmaceutical Ingredients, Solid Dose Pharmaceuticals, Sterile Injectables, Vaccines and Biopharmaceuticals; Commercial Human Prescription and Consumer Health Businesses; Global Financial Services Centre and a Global Treasury Operation. Ireland is a leading manufacturing base for Pfizer globally, exporting to global markets. Total capital investment by the company in Ireland exceeds $7billion.
Pfizer employs approximately 3,700 people at six sites in Ireland across manufacturing, shared services, R&D, treasury and commercial operations. This year Pfizer celebrates 50 years in Ireland, having invested $8 billion in operations in Ireland since opening in 1969. Many of Pfizer’s leading medicines are manufactured for global export from Irish sites.
Follow us on twitter @Pfizer_Ireland or visit


Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.

Sanofi, Empowering Life


Takeda Pharmaceutical Company Limited, a global, values-based, R&D-driven biopharmaceutical leader committed to bringing better health and a brighter future to patients by translating science into life-changing medicines, has been established in Ireland since 1997. Across Ireland, Takeda has commercial operations, corporate services and three manufacturing facilities in Bray, Dunboyne and Grange Castle.